Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

Ingelheim: Boehringer Ingelheim and Tessellate Bio, a precision oncology company, have entered into a research collaboration ...

It is predicted that the size of Korea's bio-health industry market will rank 8th in the world by 2030. As of February this ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely ...

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

Arizona's bioscience sector is growing faster than the national average, but some areas still face hurdles. Find out where ...

Pfizer, Novartis, Amgen, Eli Lilly and J&J lead pharma lobbying spend amid policy changes. Issues include 340B program, drug ...

"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

Duyk said the $30 million in funding has helped Grove Biopharma expand from "about four people working on this" to a current ...

As pharma deals with the impact of U.S. NIH grant cuts and the imposition of tariffs, a lot of pressure is shifting to ...